MedTrace Logo

The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)

NCT05113017 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-11-28

No results posted yet for this study

Summary

To prospectively evaluate the effectiveness and safety of SBRT in the treatment of residual malignant pulmonary nodules after lung cancer, and is committed to providing new treatment options for patients with multiple primary malignant pulmonary nodules who cannot tolerate multiple operations.

Conditions

  • The Efficacy and Safety of SBRT in MPLC

Interventions

OTHER

NO Intervention

NO Intervention

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    collaborator OTHER

  • The Third Xiangya Hospital of Central South University

    collaborator OTHER

  • Hunan Cancer Hospital

    collaborator OTHER

  • Fang Wu

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05113017 on ClinicalTrials.gov